sever
acut
respiratori
syndrom
coronaviru
sarscov
papainlik
proteas
plpro
reportedli
inhibit
product
type
interferon
ifn
proinflammatori
cytokin
tolllik
receptor
retino
acidinduc
gene
rigi
pathway
studi
investig
inhibitori
effect
antagonist
mechan
sarscov
plpro
cytokin
product
agonist
imiquimod
imq
concentrationdepend
induc
activ
isr
report
well
product
human
promonocyt
cell
howev
sarscov
plpro
significantli
inhibit
imqinduc
cytokin
product
suppress
activ
transcript
factor
western
blot
analysi
ubiquitin
antibodi
indic
sarscov
plpro
remov
ubiquitin
chain
ubiquitin
chain
untreat
treat
cell
decreas
activ
state
correl
inactiv
respons
imq
plpro
result
reveal
antagon
sarscov
plpro
innat
immun
associ
neg
regul
signal
tolllik
receptor
one
wellknown
pattern
recognit
receptor
sens
singlestrand
rna
virus
via
recognit
viral
rna
genom
bind
ligand
tlr
extracellular
domain
caus
homodimer
tlr
via
interact
intracellular
receptor
tir
domain
activ
myeloid
differenti
factor
depend
andor
tir
domaincontain
adaptorinduc
trif
depend
pathway
pathway
complex
activ
tlr
dimer
except
recruit
receptorassoci
kinas
irak
lead
activ
member
irak
like
activ
irak
directli
interact
tnf
examin
whether
sarscov
plpro
modul
signal
pathway
stabl
transfect
promonocyt
cell
express
plpro
vector
control
cell
establish
treat
agonist
imiquimod
imq
analyz
activ
type
ifn
product
figur
western
blot
analysi
show
band
recombin
plpro
protein
transfect
cell
control
well
similar
express
level
type
cell
figur
demonstr
sarscov
plpro
stabli
express
human
promonocyt
cell
alter
express
quantit
realtim
pcr
signifi
agonist
treatment
stimul
higher
transcript
level
vector
control
plproexpress
cell
figur
c
western
blot
analysi
cell
indic
phosphoryl
vector
control
cell
reach
maximum
level
min
disappear
min
imq
treatment
importantli
plpro
inhibit
imqinduc
activ
phosphoryl
sinc
signific
chang
phosphoryl
detect
min
imq
treatment
compar
nontreat
figur
assess
function
activ
induc
agonist
interferonstimul
respons
element
isr
report
dualluciferas
assay
perform
figur
agonist
dosedepend
trigger
isr
promot
activ
vector
control
cell
plproexpress
cell
figur
quantit
realtim
pcr
signifi
agonist
dosedepend
upregul
ifnstimul
gene
isg
includ
pkr
vector
control
plproexpress
cell
figur
c
addit
agonistinduc
activ
delay
suppress
sarscov
plpro
figur
result
reveal
plpro
suppress
agonistinduc
product
type
ifn
inhibit
activ
signal
pathway
cell
control
well
similar
express
level
type
cell
figur
demonstr
sarscov
plpro
stabli
express
human
promonocyt
cell
alter
express
quantit
realtim
pcr
signifi
agonist
treatment
stimul
higher
transcript
level
vector
control
plproexpress
cell
figur
c
western
blot
analysi
cell
indic
phosphoryl
vector
control
cell
reach
maximum
level
min
disappear
min
imq
treatment
importantli
plpro
inhibit
imqinduc
activ
phosphoryl
sinc
signific
chang
phosphoryl
detect
min
imq
treatment
compar
nontreat
figur
assess
function
activ
induc
agonist
interferonstimul
respons
element
isr
report
dualluciferas
assay
perform
figur
agonist
dosedepend
trigger
isr
promot
activ
vector
control
cell
plproexpress
cell
figur
quantit
realtim
pcr
signifi
agonist
dosedepend
upregul
ifnstimul
gene
isg
includ
pkr
vector
control
plproexpress
cell
figur
c
addit
agonistinduc
activ
delay
suppress
sarscov
plpro
figur
result
reveal
plpro
suppress
agonistinduc
product
type
ifn
inhibit
activ
signal
pathway
besid
type
ifn
product
check
whether
agonist
upregul
proinflammatori
cytokin
effect
sarscov
plpro
activ
promot
well
product
proinflammatori
cytokin
character
via
dualluciferas
report
assay
sybr
green
realtim
pcr
figur
result
indic
sarscov
plpro
inhibit
agonistinduc
activ
promot
associ
reduc
stimul
upregul
mrna
figur
b
explor
inhibitori
effect
plpro
signal
level
mapk
cjun
phosphoryl
subsequ
detect
respons
agonist
use
western
blot
figur
respect
western
blot
demonstr
plpro
suppress
agonistinduc
phosphoryl
mapk
cjun
compar
vector
control
min
posttreat
result
demonstr
sarscov
plpro
suppress
cytokin
decreas
mapk
cjun
result
suppress
signal
pathway
rel
mrna
level
pkr
b
c
normal
gapdh
mrna
present
rel
ratio
addit
activ
statu
examin
use
western
blot
antibodi
pvalu
pvalu
student
ttest
besid
type
ifn
product
check
whether
agonist
upregul
proinflammatori
cytokin
effect
sarscov
plpro
activ
promot
well
product
proinflammatori
cytokin
character
via
dualluciferas
report
assay
sybr
green
realtim
pcr
figur
result
indic
sarscov
plpro
inhibit
agonistinduc
activ
promot
associ
reduc
stimul
upregul
mrna
figur
b
explor
inhibitori
effect
plpro
signal
level
mapk
cjun
phosphoryl
subsequ
detect
respons
agonist
use
western
blot
figur
respect
western
blot
demonstr
plpro
suppress
agonistinduc
phosphoryl
mapk
cjun
compar
vector
control
min
posttreat
result
demonstr
sarscov
plpro
suppress
cytokin
decreas
mapk
cjun
result
suppress
signal
pathway
type
cell
treat
imq
h
luciferas
report
activ
mrna
level
determin
use
dual
luciferas
report
assay
quantit
pcr
b
respect
determin
activ
lysat
also
analyz
use
western
blot
antibodi
c
pvalu
student
ttest
examin
inhibitori
mechan
antagon
sarscov
plpro
differenti
profil
ubiquitinconjug
protein
vector
control
plproexpress
cell
absenc
presenc
imq
analyz
use
immuneprecipit
figur
b
autoubiquitin
traf
requir
ubiquitin
ligas
activ
sarscov
plpro
proce
deubiquitin
enzymat
activ
ubiquitin
statu
subsequ
analyz
whether
involv
signal
pathway
induc
imq
figur
immunoprecipit
assay
indic
plpro
reduc
polyubiquitin
induc
imq
figur
b
lane
vs
subsequ
western
blot
analysi
indic
imqinduc
activ
suppress
plproexpress
cell
figur
lane
vs
lane
figur
therefor
result
indic
plpro
reduc
polyubiquitin
correl
activ
mapk
signal
pathway
examin
inhibitori
mechan
antagon
sarscov
plpro
differenti
profil
ubiquitinconjug
protein
vector
control
plproexpress
cell
absenc
presenc
imq
analyz
use
immuneprecipit
figur
b
autoubiquitin
traf
requir
ubiquitin
ligas
activ
sarscov
plpro
proce
deubiquitin
enzymat
activ
ubiquitin
statu
subsequ
analyz
whether
involv
signal
pathway
induc
imq
figur
immunoprecipit
assay
indic
plpro
reduc
polyubiquitin
induc
imq
figur
b
lane
vs
subsequ
western
blot
analysi
indic
imqinduc
activ
suppress
plproexpress
cell
figur
lane
vs
lane
figur
therefor
result
indic
plpro
reduc
polyubiquitin
correl
activ
mapk
signal
pathway
studi
first
report
sarscov
plpro
show
antagonist
activ
agonistinduc
product
via
reduc
agonistinduc
phosphoryl
transcript
factor
cjun
figur
agonistinduc
stimul
transcript
activ
upregul
express
isg
pkr
vector
control
cell
figur
howev
signific
respons
signal
due
inhibitori
effect
plpro
product
agonistinduc
figur
result
constant
previou
figur
detect
ubiquitin
measur
immunoprecipit
assay
vector
control
plproexpress
cell
treat
imq
day
cell
lysat
immunoprecipit
b
follow
western
blot
probe
either
ubiquitin
ubiquitin
antibodi
level
detect
western
blot
c
rel
band
intens
normal
compar
mock
vector
control
cell
quantifi
use
imagej
base
triplic
replic
experi
studi
first
report
sarscov
plpro
show
antagonist
activ
agonistinduc
product
via
reduc
agonistinduc
phosphoryl
transcript
factor
cjun
figur
agonistinduc
stimul
transcript
activ
upregul
express
isg
pkr
vector
control
cell
figur
howev
signific
respons
signal
due
inhibitori
effect
plpro
product
agonistinduc
figur
result
constant
previou
report
sarscov
plpro
inhibit
rigimedi
product
type
interferon
proinflammatori
cytokin
via
inactiv
transcript
factor
studi
propos
crucial
regul
plpro
antagon
via
modif
profil
ubiquitinconjug
protein
vector
control
plproexpress
cell
thu
ubiquitin
linkag
statu
analyz
posttreat
imq
use
immunoprecipit
figur
immunoprecipit
assay
indic
plpro
decreas
polyubiquitin
chain
caus
decreas
ubiquitin
ligas
activ
correl
lower
level
phosphoryl
plproexpress
cell
vector
control
cell
respons
imq
plpro
report
upregul
ubiquitinconjug
enzym
proteasom
subunit
alpha
type
result
increas
polyubiquitin
plproexpress
cell
type
ifn
antagonist
mechan
sar
plpro
via
degrad
high
ubiquitin
level
plproexpress
cell
figur
b
might
respons
activ
ubiquitin
proteasom
pathway
demonstr
prior
report
find
also
similar
previou
report
inhibitori
effect
sarscov
plpro
inactiv
transcript
factor
demonstr
correl
plproreduc
ubiquitin
rigi
sting
rigi
pathway
previou
report
propos
antagonist
mechan
sarscov
plpro
includ
inhibit
signal
rigi
pathway
sinc
suggest
activ
protein
phosphatas
detect
level
phosphoryl
well
decreas
mapk
cjun
phosphoryl
vector
control
plproexpress
cell
min
postimq
treatment
figur
could
due
neg
feedback
pathway
therefor
propos
inhibit
signal
plpro
respons
antagonist
mechan
sarscov
plpro
product
type
ifn
proinflammatori
cytokin
sarscov
plproexpress
empti
vector
control
promonocyt
cell
line
establish
describ
previou
report
stablytransfect
cell
line
grew
medium
contain
fb
geneticin
select
antibiot
sulfat
express
level
plpro
stabl
cell
line
analyz
use
western
blot
antiplpro
mous
sera
mab
monitor
activ
imqinduc
signal
pathway
plproexpress
vector
control
cell
treat
imq
invivogen
san
diego
ca
usa
harvest
min
posttreat
lysat
imqtreat
cell
use
western
blot
assay
result
blot
probe
specif
primari
antibodi
mapk
mapk
cjun
phosphocjun
mab
abcam
cambridg
uk
immun
complex
detect
horseradish
peroxidaseconjug
secondari
antibodi
follow
enhanc
chemiluminesc
detect
amersham
pharmacia
biotech
piscataway
nj
usa
cisreport
plasmid
pisreluc
use
examin
firefli
luciferas
activ
driven
cisact
transcript
element
sarscov
plproexpress
vector
control
cell
transfect
indic
cisreport
plasmid
plu
intern
control
report
biosign
packard
qc
canada
use
geneport
reagent
h
incub
without
imq
activ
experiment
firefli
luciferas
control
renilla
luciferas
measur
dual
luciferas
report
assay
system
promega
madison
wi
usa
luminesc
micropl
reader
biotek
instrument
bad
friedrichshal
germani
plproexpress
empti
vector
cell
incub
h
presenc
absenc
imq
harvest
isol
total
rna
purelink
microtomidi
total
rna
purif
system
kit
invitrogen
carlsbad
ca
usa
follow
quantif
gene
express
twostep
realtim
pcr
use
sybr
green
first
cdna
synthes
total
rna
use
oligonucleotid
primer
superscript
iii
revers
transcriptas
kit
invitrogen
realtim
pcr
reaction
contain
cdna
mixtur
primer
pair
nm
smart
quant
green
master
mix
dutp
rox
protech
vancouv
wa
usa
primer
pair
includ
pkr
dehydrogenas
gapdh
realtim
pcr
perform
describ
previou
report
amplif
detect
specif
product
conduct
abi
prism
sequenc
detect
system
pe
appli
biosystem
carlsbad
ca
usa
rel
chang
mrna
level
indic
gene
normal
rel
gapdh
mrna
detect
ubiquitin
lysat
plproexpress
vector
cell
without
imq
collect
incub
specif
monoclon
antibodi
h
follow
addit
protein
asepharos
bead
addit
h
incub
centrifug
pellet
wash
four
time
net
buffer
mm
nacl
mm
edta
mm
trishcl
ph
immunoprecipit
protein
dissolv
sampl
buffer
without
boil
min
separ
sdspage
transfer
nitrocellulos
result
blot
block
skim
milk
react
specif
monoclon
antibodi
ubiquitin
follow
enhanc
chemiluminesc
detect
data
three
independ
experi
error
bar
repres
standard
error
mean
chisquar
student
ttest
use
analyz
data
statist
signific
type
cell
note
p
summari
sarscov
plpro
inhibit
signal
lead
reduc
cytokin
product
antivir
respons
plpro
diminish
ubiquitin
inactiv
downstream
molecul
kinas
mapk
transcript
factor
result
let
us
conclud
sarscov
plpro
neg
regul
signal
antivir
inflammatori
respons
